We are live on ! Find out more
NA

Neuburgh Advisers Portfolio holdings

AUM $3.22B
1-Year Est. Return 3.74%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+3.74%
3 Year Est. Return
+55.12%
5 Year Est. Return
10 Year Est. Return
AUM
$3.11B
AUM Growth
+$165M
Cap. Flow
+$95.7M
Cap. Flow %
3.08%
Top 10 Hldgs %
25.98%
Holding
938
New
28
Increased
354
Reduced
207
Closed
26

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$16.8M
2
SNA icon
Snap-on
SNA
+$12.1M
3
AAPL icon
Apple
AAPL
+$11.3M
4
DD icon
DuPont de Nemours
DD
+$10.4M
5
BNY
Bank of New York Mellon
BNY
+$9.14M

Sector Composition

Rank Sector Weight
1 Healthcare 19.09%
2 Financials 15.65%
3 Technology 15.03%
4 Consumer Discretionary 11.67%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$157M 5.06%
3,176,624
-231,968
-7% -$11.3M
SYK icon
2
Stryker
SYK
$127B
$80.1M 2.58%
389,708
+18,938
+5% +$3.62M
CVX icon
3
Chevron
CVX
$388B
$79.4M 2.56%
637,908
+48,858
+8% +$5.91M
IVV icon
4
iShares Core S&P 500 ETF
IVV
$876B
$77.9M 2.51%
264,248
+104,856
+66% +$30.4M
AMZN icon
5
Amazon
AMZN
$2.5T
$74M 2.38%
782,080
+48,320
+7% +$4.5M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.91T
$72.3M 2.33%
1,334,720
+41,600
+3% +$2.41M
JPM icon
7
JPMorgan Chase
JPM
$939B
$72.1M 2.32%
645,218
+101,184
+19% +$11.2M
MRK icon
8
Merck
MRK
$324B
$67.3M 2.17%
841,682
-57,110
-6% -$4.37M
JNJ icon
9
Johnson & Johnson
JNJ
$635B
$63.3M 2.04%
454,352
+26,816
+6% +$3.71M
FAST icon
10
Fastenal
FAST
$54B
$63.1M 2.03%
3,875,116
-530,468
-12% -$8.75M
UNH icon
11
UnitedHealth
UNH
$382B
$61.1M 1.97%
250,376
+35,836
+17% +$8.62M
TMO icon
12
Thermo Fisher Scientific
TMO
$211B
$53M 1.71%
180,466
-5,522
-3% -$1.52M
IWF icon
13
iShares Russell 1000 Growth ETF
IWF
$122B
$51.4M 1.66%
1,307,232
+1,256,096
+2,456% +$48.6M
V icon
14
Visa
V
$677B
$50.8M 1.64%
292,720
+2,288
+0.8% +$375K
BAC icon
15
Bank of America
BAC
$435B
$50.1M 1.61%
1,728,764
+275,944
+19% +$7.96M
HD icon
16
Home Depot
HD
$332B
$44.2M 1.42%
212,696
+11,594
+6% +$2.31M
BRK.B icon
17
Berkshire Hathaway Class B
BRK.B
$1.07T
$38.7M 1.24%
181,346
+23,474
+15% +$4.86M
DHR icon
18
Danaher
DHR
$135B
$38.3M 1.23%
302,110
-18,116
-6% -$2.14M
IEMG icon
19
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$36.2M 1.16%
702,882
+4,590
+0.7% +$235K
PFE icon
20
Pfizer
PFE
$140B
$33M 1.06%
803,192
-73,930
-8% -$2.94M
ORLY icon
21
O'Reilly Automotive
ORLY
$72.4B
$32.2M 1.04%
1,308,960
-124,560
-9% -$3.16M
AMT icon
22
American Tower
AMT
$77.7B
$31M 1%
151,558
-7,832
-5% -$1.57M
WMT icon
23
Walmart Inc
WMT
$871B
$30.7M 0.99%
832,458
+20,724
+3% +$714K
TJX icon
24
TJX Companies
TJX
$170B
$30.4M 0.98%
575,264
-26,224
-4% -$1.39M
FRC
25
DELISTED
First Republic Bank
FRC
$29.1M 0.94%
298,386
-21,340
-7% -$2.15M

Similar funds

Neuburgh Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Neuburgh Advisers held 938 positions worth $3.11B, up 5.6% from $2.94B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Neuburgh Advisers deployed $95.7M of net new capital in Q2 2019, opening 28 new positions and adding to 354 existing holdings. Its largest new stake was Dow Inc: 46,716 shares worth $2.3M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was RTX Corp, an estimated $16.8M trimmed.

  • Neuburgh Advisers's largest Q2 2019 buy was Dow Inc: 46,716 shares worth $2.3M.
  • Neuburgh Advisers added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $48.6M increase.
  • Neuburgh Advisers's biggest Q2 2019 reduction was RTX Corp, cutting an estimated $16.8M.
  • Neuburgh Advisers fully exited L3Harris in Q2 2019, selling an estimated $7.08M.
  • Neuburgh Advisers's ten largest holdings make up 26% of its $3.11B portfolio in Q2 2019.
  • Neuburgh Advisers opened 28 new positions and closed 26 in Q2 2019.
  • Neuburgh Advisers's portfolio value rose 5.6% quarter-over-quarter to $3.11B.

Based on Neuburgh Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.